# K202752: AXS Vecta 46 Intermediate Catheter

- Pathway: 510(k) (Traditional)
- Applicant: Stryker Neurovascular
- Decided: Aug 27, 2021 after 340 days
- Product code: QJP (Catheter, Percutaneous, Neurovasculature)
- Device class: 2
- Regulation: 21 CFR 870.1250
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 9 generations back to K003880 (2001). 14 ancestors in all.
3 later devices descend from it; 2 cite it directly.
0 of 18 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K190833: AXS Vecta Aspiration Catheter, Stryker Neurovascular (2019) Summary page 5.

## Most influential descendants
- K241244: CEREGLIDE 42 Intermediate Catheter; CEREGLIDE 57 Intermediate Catheter (2024), 1 descendant of its own
- K261176: Zoom 4S Catheter (2026), 0 descendants of its own
- K262398: CEREGLIDE 57 Intermediate Catheter; Cerenovus Aspiration Tubing set (2026), 0 descendants of its own

## Indications for use
The AXS Vecta Intermediate Catheter is indicated for use in facilitating the insertion and guidance of appropriately sized interventional devices into a selected blood vessel in the neurovascular system. The AXS Vecta Intermediate Catheter is also indicated for use as a conduit for retrieval devices.

Source page: https://510kreport.com/device/K202752
Methodology: https://510kreport.com/methodology